Clinical Trial Update: Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection [Phase 1]

View source ↗

Summary

Phase 1 study evaluating bacteriophage therapy for periprosthetic joint infection; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periprosthetic Joint Infection

Drugs mentioned

• Bacteriophage therapy

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Periprosthetic Joint Infection | Phase 1 | Status: ACTIVE_NOT_RECRUITING